investigators found EBV genomes in up to 25% of DNA extracts from HD tissue biopsies analyzed by direct filter hybridization methods.6-10 Because of the limited sensitivity of this approach, these studies were extended by the application of the polymerase chain reaction (PCR) technique, which showed DNA sequences in considerably larger proportions of cases, ranging between 40% and 80% depending on the sensitivity limits applied.1i-18 Although most investigators found approximately 55% to 60% of the HD cases to contain substantial amounts of EBV DNA, the significance of these findings remained controversial. Several investigators favored tumor cells, rather than cells of the reactive admixture, as the most probable origin of the EBV DNA, and this view was substantiated by the visualization of EBV DNA8-11,i9,20 and of the EBV-encoded latent membrane protein (LMP) exclusively in Hodgkin and Reed-Sternberg (H-RS) cells in up to 40% and 48% of HD 
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of DNA extracts from HD tissue biopsies analyzed by direct filter hybridization methods.6-10 Because of the limited sensitivity of this approach, these studies were extended by the application of the polymerase chain reaction (PCR) technique, which showed DNA sequences in considerably larger proportions of cases, ranging between 40% and 80% depending on the sensitivity limits applied.1i-18 Although most investigators found approximately 55% to 60% of the HD cases to contain substantial amounts of EBV DNA, the significance of these findings remained controversial. Several investigators favored tumor cells, rather than cells of the reactive admixture, as the most probable origin of the EBV DNA, and this view was substantiated by the visualization of EBV DNA8-11,i9,20 and of the EBV-encoded latent membrane protein (LMP) exclusively in Hodgkin and Reed-Sternberg (H-RS) cells in up to 40% and 48% of HD cases, r e~p e c t i v e l y .~~,~~ Others pointed out that most of the EBV genomes detected in tissue extracts could have been derived from EBV-carrying cells of the reactive admixt~r e . l~-~~ More than 90% of adults worldwide are latently infected with this herpesvirus, so that at least some latently infected lymphocytes are likely to be present in almost any lymphoid tissue.22 It was thus argued that the sensitivity limits of in situ hybridization did not permit detection of EBV DNA in the cellular admixture,14 raising the possibility that, although responsible for the frequent detection of EBV in HD by PCR, an abundance of EBV-infected cells remained undetected by in situ hybridization for EBV DNA.
Detection of the small EBV-encoded nonpolyadenylated RNA transcripts, EBERl and EBER2, by in situ hybridization now provides a way to clarify this issue. This approach has previously been applied to various EBV-associated lesions, such as undifferentiated nasopharyngeal carcioral hairy l e~k o p l a k i a ,~~ CD30+ anaplastic largecell lymphoma,25 and to a limited number of HD case^.^^.^'
The EBERs appear to be transcribed in most human lesions associated with latent EBV infection.28 By virtue of their extreme abundance, estimated to be up to lo6 copies per viral genome?9 EBERs lend themselves to the application of radioactive and nonradioactive in situ hybridization, even in routinely formalin-fixed and paraffin-embedded t i s~u e s .~~-~7 For the present study, we used in sitti hybridization with EBER-specific single-stranded 
MATERIALS AND METHODS
Lymph node biopsy specimens from 46 HD patients submitted for histopathological diagnosis were routinely processed Tissues. 484 Blood, Vol80, No 2 (July 15). 1992: pp 484-491
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 485 by formalin fixation and paraffin embedding. In six cases, snapfrozen aliquots of the tissues, stored at -8O"C, were available. Development of the disease was unrelated to human immunodeficiency virus (HIV) infection, and none of these cases was incorporated into previous studies. Histological typing followed the Rye classification. Ten lymph nodes, removed during mastectomy or prostatectomy and showing a regular histology with only moderate sinus histiocytosis, were used as controls.
The production and specificity profiles of the monoclonal antibodies specific for LMP (clones CS1, -2, -3, and -4)% and of a rabbit antiserum directed against LMP?I are described elsewhere. Monoclonal antibodies against CD20 (L26), CD30 (Ber-Hr2), and CD68 (KP-l), as well as CD3-specific rabbit antibodies, were obtained from Dakopatts (Glostrup, Denmark). The anti-T-cell receptor P-chain antibody, PF1, was from T-cell Sciences (Cambridge, MA), and the CD45RO-specific antibody A633 was a kind gift of Dr G.G. Aversa (Stanford, CA). Sections (4 km) of either formol-fixed/paraffin-embedded or snap-frozen tissue blocks were stained by the immunoalkaline phosphatase (APAAP) method." Affinity-purified mouse anti-rabbit immunoglobulin, rabbit anti-mouse immunoglobulin antibodies, and APAAP complex (diluted 1:20) were obtained from Dakopatts.
Incubation with the CD3-specific antibodies was performed overnight. Formol-fixed sections required a proteolytic treatment with 1 mg/mL Streptomyces giseus protease (Sigma, Deisenhofen, Germany) for 10 minutes before incubation with the monoclonal antibodies PF1 and Ber-H2.
EBER1-and EBERZspecific fragments were derived from the plasmids pJJJl and P J J J~,~~ kindly provided by Dr J. Arrand (Manchester, UK), and subcloned into the BamHIIEcoRI and EcoRIIHindIII sites, respectively, of the transcription vector pBluescriptKS (Promega-Biotec, Madison, WI). For the preparation of IgLC RNA probes, the 550-bp SstI fragment containing the human IgLCK gene constant segment?6 and the 600-bp BglIII BumHI fragment containing the IgLCX gene C2 constant segm e~~t ?~ respectively, were subcloned into pGEMl (Promega Biotec). Phages with the IgLCK and IgLCX genomic fragments were kindly provided by Dr P. Leder, (Cambridge, MA). After linearization with the appropriate restriction enzymes (GIBCO-BRL, Karlsruhe, Germany), [35S]-labeled antisense or sense (control) run-off transcripts were generated using either SP6, T3, or T7 RNA polymerases and [35S]-uridine-5'-(u-thio)-triphosphate (1, 250 Ci/mmol; New England Nuclear, Dreieich, Germany) or, altematively, digoxigenin-ll-uridine-5'-triphosphate (Boehringer Mannheim, Mannheim, Germany).38 A mixture of EBER1-and EBER2-specific RNA probes was applied to increase the sensitivity.
The hybridization procedure with either [35S]-labeled, digoxigenin-labeled, or combinations of [35S]-and digoxigenin-labeled probes on frozen and paran-sections, washing steps including RNase digestion of nonspecifically bound probe, and autoradiography were performed as described.25 Immobilized digoxigenin was detected using a monoclonal digoxigeninspecific antibody (Boehringer Mannheim; dilution 1:20) and the APAAP procedure. All sections were processed in parallel using the same batches of reagents and probes. Abrogation of specific signals in hybridizations preceded by micrococcal nuclease digest i~n~~ verified that the targets of the hybridizations were RNA molecules. The specificity of the EBER probes was further tested on six HD-derived cell lines: of which only the line L591, known to harbor EBV,6 expressed EBERl and EBER2.
Cryostat sections fixed in 4% paraformaldehyde were incubated in 2 mg/mL predigested pronase/lx phosphate-buffered saline (PBS) at 37°C for 5 minutes. Slides were rinsed twice with 0.1 mol/L glycine/lx Tris-buffered saline (TBS). Antibodies were used in Immunohistology.
Probes.
In situ hybridization.
Sequential immunohistochemistry and in situ hybridization. freshly prepared RPMI 1640 medium (GIBCO-BRL), pH 7.5, containing 10 mg/mL bovine serum albumin, 1.0 mg/mL yeast tRNA, and 5,000 U/mL heparin ammonium salt (Sigma) to inhibit RNase activity.'IQ4* Incubation was 30 minutes at room temperature each with the monoclonal antibody, rabbit anti-mouse immunoglobulin antibody, and APAAP complex (Dakopatts), the latter two in 1:20 dilution, using RPMI dilution buffer as described above. The last two incubation steps were repeated once for 10 minutes each. Washing after each incubation step was done in lx TBS. Immobilized antibodies were visualized as described above and slides were immediately subjected to the in situ hybridization procedure. Paraffin sections were similarly treated following dewaxing in xylene and predigestion in 0.5 mg/mL protease VI11 (Sigma) in PBS for 8 minutes at room temperature; these further procedures did not differ from those for cryostat sections. Autoradiographic exposure was 4 to 6 days. To estimate the RNA loss during immunostaining procedures, adjacent tissue sections were subjected to in situ hybridization not preceded by immunostaining. The autoradiographic exposure times for slides subjected to the double-labeling procedure were adjusted accordingly.
RESULTS
Histological diagnoses and phenotype characteristics of 46 HD cases are summarized in Table 1 . Twenty-three cases showed EBER expression in neoplastic cells, while the other 23 cases did not display an EBER-specific signal in any of the H-RS cells even after prolonged autoradiographic exposure. The intensity of the EBER-specific in situ hybridization signal over H-RS cells varied considerably from cell to cell; short exposure times (6 to 12 hours of autoradiography) were particularly useful to assess the atypical nuclear morphology of EBER+ H-RS cells, whereas extended exposure times ( > 4 days) resulted in exhaustion of the capacity of the autoradiographic emulsion over most EBER+ cells and were useful to establish the total number of such cells. The number of EBER+ cells was matched by the number of CD30+ cells in adjacent tissue sections. Thus in these HD cases, virtually all H-RS cells, and not only a proportion, expressed EBER transcripts. Hybridization with sense (control) probes resulted in background signals over all cells. Eighteen of 23 cases with EBER+ H-RS cells displayed LMP expression in 10% to 80% of the neoplastic cells, as detected in paraffin sections. In comparison with the monoclonal antibodies, CS1-4, the LMP-specific rabbit antiserum stained smaller percentages of neoplastic cells.
Unlike LMP expression, EBER transcripts were not restricted to H-RS cells. In most cases, small lymphoid cells with unsuspicious nuclear morphology were found in small numbers (Table 2) . regardless of whether the neoplastic cells were EBV-infected (Fig 1) (Fig 2) .
To further characterize EBER-expressing cells, nine HD cases, particularly cases with either an EBER-or EBER+/ CD20-/CD45RO-/TcRp-H-RS cell phenotype, were subjected to the sequential immunohistology/isotopic in situ hybridization double-labeling procedure on frozen and paraffin sections using antibodies against CD20, CD30, CD45R0, CD68, LMP, and the TcRp-chain. In cases with EBER+ H-RS cells, CD30-specific staining virtually matched with EBER expression (Fig 3, Table 3 ). LMP staining was always associated with EBER-specific autoradiographic signals, and CD68 reactivity was not coexpressed with EBER in any of the cases. Approximately 6 of 10 EBER+ reactive cells were detected by the CD20 antibody L26 in For personal use only. on October 3, 2017. by guest www.bloodjournal.org From For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Per 100 EEER+ and/or CD30+ cells; H-RS cells were identified by morphology and immunophenotype at the first time point, and at the second time point by CD3O-specific staining only, because the nuclear morphology was concealed by the autoradiographic signal.
cryostat sections (Fig 4) . In paraffin sections, the proportion of EBER+/CD20+ small cells was considerably lower and the staining was reduced to weak signal intensity, whereas neighboring EBER-/CD20+ cells were still strongly labeled (Figs 5 and 6). Furthermore, an HD case with CD20+/EBER+ H-RS cells showed an intense CD20 staining of the EBER-labeled tumor cells, further excluding a mere technical problem resulting in reduced immunoreactivity of EBER+ small cells. Unambiguous reactivity of EBER+ small cells with the TcRp-specific antibody PF1 or the antibody A6 (CD45RO) was not found in any of the tissues (Fig 7) . EBER+ reactive cells were thus either of B-cell phenotype (CD20+/IgLC+) or could not be assigned to a particular lineage.
DISCUSSION
Detection of the highly abundant EBER transcripts represents a considerable technical advancement in the study of EBV infection, because it permits visualization of practically all latently EBV infected cells in tissue sections. In contrast to DNA-DNA in situ hybridization, use of single-stranded antisense EBER-specific RNA probes and removal of nonspecifically bound probe by ribonuclease digestion result in low background signal and facilitate discrimination between EBV+ and EBV-~e l l s . 2~-~~ It is thus possible to address some of the questions that remained open in previous studies, eg, as to the presence of EBV in mainly neoplastic or reactive cells in HD tissue biopsies, and their number, distribution, and phenotype.
In situ hybridization for the detection of EBER transcripts showed the presence of EBV in H-RS cells of 23 of 46 HD cases that were not included in any of our previous reports. Except for the two cases of HDlp, which may be not representative, HDmc was the histological type of the disease most frequently associated with the virus, followed by HDns. These results are well in agreement with a recently published study describing EBER+ H-RS cells in 11 of 23 cases of typical HD." LMP was detectable by immunohistology in variable proportions of EBER+ neoplastic cells of 18 cases. This figure supports the view that previous studies using EBV DNA in situ hybridizati~n~-~lJ~ or LMP i m m u n o h i~t o l o g y~~~~~~~~ slightly underscored the exact proportion of HD cases with EBV-harboring tumor cells, whereas PCR studieW3 may have overestimated this figure. Extension of the autoradiographic exposure time in combination with CD30-specific immunostaining verified that virtually all, and not only a subset, of the neoplastic cells harbored EBV in HD cases with EBER+ H-RS cells.
In frozen sections, CD30 staining identifies practically all H-RS cells in nearly all HD
This observation is of importance in the context of previous demonstrations of monoclonality of EBV genomes in HD tissue extracts,5Y8-l0 and further supports the notion that infection of the neoplastic cells by EBV must have occurred before their clonal expansion. The EBV infection is thus placed in an appropriate time frame to have a role in the etiology of HD. LMP expression in H-RS cells additionally supports this concept because of the transforming potential of this gene product in several experimental ~ystems.4~ LMP, which is variably expressed during the course of the cell cycle,44 upregulates bcl-2 protein expression and, by this mechanism, prevents programmed cell death in B cells. 45 The presence of monoclonal EBV genomes and LMP expression in H-RS cells is the most frequent abnormality with established oncogenic potential among HD cases and supports the concept of an etiologic role of EBV in the pathogenesis of a significant proportion of HD cases. However, the presence of EBV in H-RS cells is restricted to a subset of HD, and certainly more than one immortalizing or transforming mechanisms are required for the generation of malignant CD30+ cells. Therefore, more information, particularly on the interaction of EBV gene products with cellular genes and proteins, is needed to conclusively assess the significance of the presently available data for the pathogenesis of HD and other EBV-associated malignancies.
EBV was not restricted to neoplastic cells in biopsies from HD patients. Variable, usually small numbers of EBER+ reactive lymphoid cells were found in HD cases with EBER+ or EBER-H-RS cells. Absolute numbers could be determined precisely in cases without EBV infection of H-RS cells. In addition to the cytomorphologic aspect, sequential double-labeling using markers not expressed by the neoplastic cell population proved helpful to estimate the frequency of EBER+ reactive cells in tissues with EBER+ H-RS cells. Some cases did not display any EBER+ cells even in serial sections. This absence of EBER expression did not represent a problem of tissue preservation, because IgLC gene transcripts could be detected in plasma cells and B cells. The presence of EBER+ reactive cells in only very small numbers, or even their absence, in most cases is likely to explain why EBER+ reactive cells were not described in a previous report on EBER expression in HD.26 With respect to the normal lymph node tissues, similar results were obtained in a study focusing on nonmalignant lymphoid lesions.& The observation of EBER+ cells in only a low proportion of normal lymph nodes is in apparent contradiction to the fact that worldwide more than 90% of the population is seropositive for EBV-specific antibodies. Quantitative evaluation of EBVinfected peripheral blood cells, on the other hand, showed a very low frequency of EBV+ cells (1 to 5 infected cells per lo7 mononuclear leukocytes) in healthy donors," which is in good agreement with the histomorphological findings. Furthermore, antibody titers are unlikely to be determined only by EBV infection of lymphoid cells, because epithelial cells also represent targets for this herpes Immunophenotyping of reactive EBER+ cells was problematic and, particularly in paraffin sections, virtually impossible for the vast majority of these cells. In frozen sections, most of the small EBER+ cells could be stained with the antibody L26 (CD20). However, in paraffin sections, the number of these cells was reduced. CD20+ /EBER-reactive cells and CD20+ /EBER+ tumor cells, on the other hand, could be detected easily with our immunohistological procedure. These observations, in conjunction with the IgLC+ phenotype of most EBER+ small cells and the established immunophenotype of resting and activated, noninfected B lymphocytes as constantly CD20+ cells,@ led us to conclude that expression of the CD20 antigen may be downregulated in latently EBV-infected small lymphoid cells in vivo. The CD20 antigen directly regulates transmembrane ion flux in B lymphocytes and is a key structure for antigen-independent B-cell activati0n.4~ Downregulation of this activation-associated antigen may thus have specific advantages for EBV-harboring cells. To test this hypothesis, it will be necessary to quantitate the density of CD20 and other antigens on suspended cells, and nonisotopic EBER-specific labeling may facilitate the identification of EBV-infected cells in such experiments. LMP expression was not observed in any of the reactive cells, which is in keeping with published data,13.z1 and may facilitate evasion of these cells from immune recognition. This interpretation is also supported by the previously established absence of the EBNA2 latent gene prod-U C~~~,~~,~~ and EBV lytic cycle antigens (early antigen,5O viral capsid a~~tigen,l~?~O and gp250/350 membrane antigen13) from any cells in HD tissues.
In general, the majority of EBER+ cells were of (CD20+)/ IgLC+/LMP-phenotype, whereas EBER+ /TcRP+ or EBER+/CD45RO+ cells, ie, mature T cells, were not detectable. This raises the possibility that immature lymphoid cells, ie, cells with incomplete or missing antigen receptor gene rearrangements cells, were among the EBER+/IgLC-subp~pulation.~~ However, our estimate of the proportions of EBER+ B and T cells is largely based on cases with elevated numbers of EBER+ reactive cells, which may not be representative for HD cases with small numbers of EBER+ reactive cells. The presence of CD43+ EBV-infected cells in addition to occasional B cells was recently observed in some cases of HD, and interpreted as evidence for a T-cell nature of these CD43+ cells.27 However, CD43 antigen is not lineage-specific; moreover, it is found on many EBV+ lymphoblastoid B-cell lines.52 Thus, whereas EBER+/TcRP+/CD45RO+ small cells arising in certain pediatric immunodeficiency syndromes can be identified with our methodology (H. Herbst, unpublished observation), it must be concluded that such EBER+ mature T cells, if present at all, appear to be extremely rare in lymph nodes from normal adults and HD patients.
The frequency of EBER+ cells in the reactive admixture was slightly higher when compared with nonhyperplastic control lymph nodes, but their phenotypic properties were similar. The two groups of HD, with or without EBVharboring H-RS cells, respectively, did not differ from each other with regard to the occurrence, frequency, and phenotype of reactive EBER+ cells. Thus, in the majority of HD patients, the postulated specific isolated immune defect that permits proliferation of tumor cells expressing a viral neo-antigen, LMP, is obviously not accompanied by an unrestricted proliferation of reactive EBER+ lymphoid cells. This is in sharp contrast to the pattern seen during infectious mononucleosis,53 as well as in lymph nodes of immunosuppressed transplant recipients or HIV-infected individuals, who generally display larger numbers of EBER+ cells.& It is thus likely that there are distinct immunological differences between patients with global immunodeficiencies, which are at risk to develop EBV-induced oligoclonal or monoclonal non-Hodgkin's lymph0ma,5~9~~ on the one side, and HD patients on the other.
